Levert H et al. |
Azithromycin impact on neutrophil oxidative metabolism depends on exposure time. |
1998 |
Inflammation |
pmid:9561928
|
Hoppe JE and Bryskier A |
In vitro susceptibilities of Bordetella pertussis and Bordetella parapertussis to two ketolides (HMR 3004 and HMR 3647), four macrolides (azithromycin, clarithromycin, erythromycin A, and roxithromycin), and two ansamycins (rifampin and rifapentine). |
1998 |
Antimicrob. Agents Chemother. |
pmid:9559823
|
Dietz A et al. |
[Macrolide antibiotic-induced vasculitis (Churg-Strauss syndrome)]. |
1998 |
Laryngorhinootologie |
pmid:9555706
|
Mortensen JE et al. |
In vitro activity of oral antimicrobial agents against clinical isolates of Pasteurella multocida. |
1998 |
Diagn. Microbiol. Infect. Dis. |
pmid:9554176
|
Hoepelman IM et al. |
A short (3-day) course of azithromycin tablets versus a 10-day course of amoxycillin-clavulanic acid (co-amoxiclav) in the treatment of adults with lower respiratory tract infections and effects on long-term outcome. |
1997 |
Int. J. Antimicrob. Agents |
pmid:9552709
|
Chakrabarti MK et al. |
Evaluation of different antibiotics in inhibiting colonization of Vibrio cholerae O1 and O139 in the rabbit intestine. |
1998 Mar-Apr |
Chemotherapy |
pmid:9551241
|
Walsh T et al. |
Randomised controlled trial of prophylactic antibiotics before insertion of intrauterine devices. IUD Study Group. |
1998 |
Lancet |
pmid:9546505
|
Mizutani S |
[Nontuberculous mycobacteriosis; the present status and in the future. Infection with human immunodeficiency virus (HIV) and nontuberculous mycobacteriosis]. |
1998 |
Kekkaku |
pmid:9545702
|
Karcioglu ZA et al. |
Pharmacokinetics of azithromycin in trachoma patients: serum and tear levels. |
1998 |
Ophthalmology |
pmid:9544640
|
Jucglà A et al. |
The use of azithromycin for cyclosporin-induced gingival overgrowth. |
1998 |
Br. J. Dermatol. |
pmid:9536254
|
Kemper CA et al. |
Immunomodulatory treatment of Mycobacterium avium complex bacteremia in patients with AIDS by use of recombinant granulocyte-macrophage colony-stimulating factor. |
1998 |
J. Infect. Dis. |
pmid:9534963
|
Rajyaguru JM and Muszynski MJ |
Sensitization of Burkholderia cepacia to antibiotics by cationic drugs. |
1998 |
J. Antimicrob. Chemother. |
pmid:9533472
|
Dzelalija B et al. |
[Azithromycin in the prevention of Mediterranean spotted fever]. |
1997 |
Lijec Vjesn |
pmid:9531759
|
Socan M |
Treatment of atypical pneumonia with azithromycin: comparison of a 5-day and a 3-day course. |
1998 |
J Chemother |
pmid:9531077
|
Leri O et al. |
[Effects of the triple therapy in the eradication of Helicobacter pylori: comparison of 3 different antibiotics]. |
1997 |
Clin Ter |
pmid:9528197
|
Kashuba AD and Amsden GW |
Bronchopulmonary pharmacokinetics of clarithromycin and azithromycin. |
1998 |
Antimicrob. Agents Chemother. |
pmid:9527816
|
Fuentes F et al. |
Postanitbiotic and sub-MIC effects of azithromycin and isepamicin against Staphylococcus aureus and Escherichia coli. |
1998 |
Antimicrob. Agents Chemother. |
pmid:9527796
|
den Hollander JG et al. |
Comparison of pharmacodynamics of azithromycin and erythromycin in vitro and in vivo. |
1998 |
Antimicrob. Agents Chemother. |
pmid:9527789
|
Oldfield EC et al. |
Once weekly azithromycin therapy for prevention of Mycobacterium avium complex infection in patients with AIDS: a randomized, double-blind, placebo-controlled multicenter trial. |
1998 |
Clin. Infect. Dis. |
pmid:9524832
|
Bowden FJ and Savage J |
Donovanosis: treatment with azithromycin. |
1998 |
Int J STD AIDS |
pmid:9518024
|